Loading...
•
Sep 30, 2023
Humana Q3 2023 Earnings Report
Humana reported strong earnings growth driven by Medicaid and Primary Care businesses, with a focus on operating efficiencies, offset by higher Medicare Advantage utilization.
Key Takeaways
Humana reported Q3 2023 GAAP EPS of $6.71 and adjusted EPS of $7.78. The company is revising its FY 2023 GAAP EPS guidance to at least $26.31, while affirming its adjusted EPS guidance of at least $28.25. Individual Medicare Advantage membership growth is expected to be approximately 860,000, a 19% increase year-over-year.
Reported 3Q23 GAAP EPS of $6.71 and Adjusted EPS of $7.78.
Revised FY 2023 GAAP EPS guidance to at least $26.31 and affirmed FY 2023 Adjusted EPS of at least $28.25.
Increased 2023 individual Medicare Advantage membership growth to approximately 860,000, a 19 percent increase over FY 2022.
Achieved 94 percent of Medicare Advantage members enrolled in 4-star and above contracts for 2024.
Humana
Humana
Humana Revenue by Segment
Revenue by Segment
Insurance Revenue
CapyFin.com Forward Guidance
Humana revised its GAAP EPS guidance for the year ending December 31, 2023 (FY 2023) to 'at least $26.31' from 'at least $26.91', while affirming its Adjusted EPS guidance of 'at least $28.25'.